Chondromyxoid fibroma management: a single institution experience of 22 cases

World Journal of Surgical Oncology

Timothy WR Briggs¹  Asif Saifuddin¹  William J Aston¹  John A Skinner¹  Robin C Pollock¹  Roberto Tirabosco¹  Panos D Gikas¹  Baljinder S Dhinsa¹  Hesham Al-Khateeb¹  Jagmeet S Bhamra¹ 

[1]Bone Tumour Unit, The Royal National Orthopaedic Hospital, Stanmore, Middlesex HA7 4LP, UK

关键词: Protocol;    Management;    Case series;    Functional outcome;    Cementation;    Curettage;    Chondromyxoid fibroma;   

Others  :  1148119
DOI  :  10.1186/1477-7819-12-283

 received in 2013-12-20, accepted in 2014-09-02,  发布年份 2014

【 摘 要 】

Background

Several different strategies have been reported for the treatment of chondromyxoid fibromas, all with variable outcomes and high recurrence rates.

Methods

We report on 22 consecutive cases of chondromyxoid fibromas treated by intralesional curettage, four of which had adjuvant cementation at our institution between 2003 and 2010. We assessed the functional outcome using the Musculoskeletal Tumour Society (MSTS) scoring system.

Results

Nine males and 16 females with a mean age of 36.5 years (range 11 to 73) and a mean follow-up of 60.7 months were included in the study. Local recurrence occurred in two patients (9%) within the first 2 years following the index procedure. This was treated by re-curettage only of the residual defect. Two postoperative complications occurred: a superficial wound infection in one patient and a transient deep peroneal nerve neurapraxia in the other. The mean postoperative MSTS score was 96.7%.

Conclusions

Intralesional curettage and cementation is as an effective treatment strategy for chondromyxoid fibromas, providing satisfactory functional results with a low recurrence rate. Careful case selection with stringent clinical and radiographic follow-up is recommended.

【 授权许可】

   
2014 Bhamra et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Campanacci M, Bertoni F, Bacchini P: Bone and Soft Tissue Tumors. New York: Springer- Verlag; 1990.
• [2]Unni KK: Chondromyxoid fibroma. Dahlin’s Bone Tumors. General Aspects and Data on 11,087 Cases. 5th edition. Philadelphia: Lippincott, Williams & Wilkins; 1996:59-69.
• [3]Wu CT, Inwards CY, O’Laughlin S, Rock MG, Beabout JW, Unni KK: Chondromyxoid fibroma of bone: a clinicopathologic review of 278 cases. Hum Pathol 1998, 29:438-446.
• [4]Jaffe H, Lichtenstein L: Chondromyxoid fibroma of bone. Arch Pathol 1948, 45:541.
• [5]Brat HG, Renton P, Sandison A, Cannon S: Chondromyxoid fibroma of the sacrum. Eur Radiol 1999, 9:1800-1803.
• [6]Gherlinzoni F, Rock M, Picci P: Chondromyxoid fibroma. The experience at the Istituto Ortopedico Rizzoli. J Bone Joint Surg 1983, 65:198-204.
• [7]Anderson WJ, Bowers WH: Chondromyxoid fibroma of the proximal phalanx. A tumour that may be confused with chondrosarcoma. J Hand Surg 1986, 11:144-146.
• [8]Desai SS, Jambhekar NA, Samanthray S, Merchant NH, Puri A, Agarwal M: Chondromyxoid fibromas: a study of 10 cases. J Surg Oncol 2005, 89:28-31.
• [9]Merine D, Fishman EK, Rosengard A, Tolo V: Chondromyxoid fibroma of the fibula. J Pediatr Orthop 1989, 9:468-471.
• [10]Rahimi A, Beabout JW, Ivins JC, Dahlin DC: Chondromyxoid fibroma: a clinicopathologic study of 76 cases. Cancer 1972, 30:726-736.
• [11]Schajowicz F, Gallardo H: Chondromyxoid fibroma of bone. A clinico-pathological study of thirty-two cases. J Bone Joint Surg 1971, 53:198-216.
• [12]Lersundi A, Mankin HJ, Mourikis A, Hornicek FJ: Chondromyxoid fibroma: a rarely encountered and puzzling tumor. Clin Orthop Relat Res 2005, 439:171-175.
• [13]Başbozkurt M, Ateşalp S, Şarlak AY, Tunay S, Yıldırım Y: Chondromyxoid fibroma [in Turkish]. Deniz Tıp Bülteni 1993, 26:95-99.
• [14]Kervancıoğlu S, Kervancıoğlu R, Şirikçi A, Özkur A: Solid aneurysmal bone cyst of the clavicle: a case report in a child [in Turkish]. Tanısal Girişimsel Radyoloji 2002, 8:299-301.
• [15]Wilson AJ, Kyriakos M, Ackerman LV: Chondromyxoid fibroma: radiographic appearance in 38 cases and in a review of the literature. Radiology 1991, 179:513-518.
• [16]Durr HR, Lienemann A, Nerlich A, Stumpenhausen B, Refior HJ: Chondromyxoid fibroma of bone. Arch Orthop Trauma Surg 2000, 120:42-47.
• [17]Murata H, Horie N, Matsui T, Akai T, Ueda H, OShima Y, Konishis E, Kubo T: Clinical usefulness of thallium-201 scintigraphy and magnetic resonance imaging in the diagnosis of chondromyxoid fibroma. Ann Nucl Med 2008, 22:221-224.
• [18]O’Connor P, Gibbon W, Hardy G, Butt W: Chondromyxoid fibroma of the foot. Skel Radiol 1996, 25:143-148.
• [19]Hau MA, Fox EJ, Rosenberg AE, Mankin HJ: Chondromyxoid fibroma of the metacarpal. Skel Radiol 2001, 30:719-721.
• [20]Kim HS, Jee WH, Ryu KN, Cho KH, Suh JS, Cho JH, Choi YS, Lee SM, Lee JM, Sung MS, Kim JY, Jung ES, Chung YG, Ok IY: MRI of chondromyxoid fibroma. Acta Radiol 2011, 52:875-880.
• [21]Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ: A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res 1993, 286:241-246.
• [22]Hanna SA, Whittingham-Jones P, Sewell MD, Pollock RC, Skinner JA, Saifuddin A, Flanagan A, Cannon SR, Briggs TW: Outcome of intralesional curettage for low-grade chondrosarcoma of long bones. Eur J Surg Oncol 2009, 35:1343-1347.